MOLECULAR AND CLINICAL CORRELATES WITH PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) - TARGETED RADIONUCLIDE THERAPY

Dana-Farber Cancer Institute, Inc.

Investigators